La vendita allo scoperto per Sight Sciences dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Sight Sciences. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Sight Sciences (NASDAQ:SGHT) Azioni, Report sulle vendite allo scoperto

SIGHT SCIENCES INC

Sight Sciences

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.

EMPG

Trading Halt: Halt status updated at 11:50:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation

Trading Ideas

SONN

Sonnet BioTherapeutics Shares Resume Trade Following Circuit Breaker Halt

Jefferies analyst Edison Lee upgrades Apple (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) from Underperform to Hold and raises the price target from $170.62 to $188.32.

News

Upgrades

Price Target

Analyst Ratings

AAPL

Jefferies Upgrades Apple to Hold, Raises Price Target to $188.32

Alphabet Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>), one of the most dominant players in the Magnificent 7 tech group, is now trading at a price-to-earnings ratio that's historically associated with powerful stock rallies, setting up what could be<a href="https://www.benzinga.com/markets"> a rare buying opportunity.</a>
<h2 class="wp-block-heading">What Is A P/E Ratio And Why Does It Matter?</h2>
The price-to-earnings ratio (P/E) measures how much investors are willing to pay for each dollar of a company's profit. 
A lower P/E can signal that a stock is undervalued relative to its earnings, especially when compared to its historical average or industry peers.
As of July 2, Alphabet trades at 19.8 times its trailing 12-month earnings. That&#8217;s 16% below its 20-year average of 32, putting it near valuation levels rarely seen over the past two decades. 
<h2 class="wp-block-heading">How Rare Is This Valuation Level For Alphabet?</h2>
The last time Alphabet traded at this low a P/E ratio was in May 2025, when it briefly touched 17.1x. That was just shy of the record low of 16.2x seen on November 12, 2008, during the depths of the financial crisis.
Other low-P/E episodes include June 2011, March 2012 and September 2022. 
Each of those moments came before significant long-term rallies in the stock.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="529" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/02112640/image-31-1024x529.png" alt="" class="wp-image-970679" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/02112640/image-31-1024x529.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/02112640/image-31-300x155.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/02112640/image-31-768x397.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/02112640/image-31-1536x794.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/02112640/image-31-2048x1059.png 2048w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
<h2 class="wp-block-heading">What Happened To Alphabet Stock After Previous Low P/E Readings?</h2>
Historical data suggests that buying Alphabet at discounted valuations has been a profitable long-term strategy.
Every time its price-to-earnings ratio (P/E) fell below 20 in the past two decades, investors who stayed the course for a year or more reaped far better returns than usual.
After hitting its record-low valuation in 2008, Alphabet returned 88% in just one year and 68.1% over the next two years. The post-2011 and 2012 recoveries were also strong, delivering gains of 73.2% and 71%, respectively, over the two years.
Even after the September 2022 dip, when Alphabet fell into a bear market with a P/E ratio of nearly 19, the stock rallied 32% over the next 12 months and 51.2% within 24 months.
Across the four historical periods when Alphabet traded below 20 times earnings, the average 2-year return was a remarkable 65.9%, while the 1-year gain averaged 38.5%—more than double its 20-year annualized return of 17.3%.
In contrast, short-term performance was mixed. One-month returns after low P/E events averaged -1.6%, while three-month gains averaged just 2.7%. The real upside consistently showed up after one year or more.
A look at Alphabet's past performance shows a clear pattern: the bigger gains came with patience. 
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<thead>
<tr>
<th>Date</th>
<th>$GOOGL Price</th>
<th>1-Month (%)</th>
<th>3-Month (%)</th>
<th>6-Month (%)</th>
<th>12-Month (%)</th>
<th>24-Month (%)</th>
</tr>
</thead>
<tbody>
<tr>
<td>November 12, 2008</td>
<td>$7.28</td>
<td>4.5</td>
<td>20.2</td>
<td>32.1</td>
<td>88.0</td>
<td>68.1</td>
</tr>
<tr>
<td>June 10, 2011</td>
<td>$12.75</td>
<td>2.6</td>
<td>3.1</td>
<td>21.7</td>
<td>11.0</td>
<td>73.2</td>
</tr>
<tr>
<td>March 30, 2012</td>
<td>$16.05</td>
<td>-7.2</td>
<td>-10.9</td>
<td>16.9</td>
<td>22.9</td>
<td>71.0</td>
</tr>
<tr>
<td>September 14, 2022</td>
<td>$105.00</td>
<td>-8.1</td>
<td>-9.1</td>
<td>-10.1</td>
<td>32.0</td>
<td>51.2</td>
</tr>
<tr>
<td>March 28, 2025</td>
<td>$154.33</td>
<td>0.1</td>
<td>10.2</td>
<td>—</td>
<td>—</td>
<td>—</td>
</tr>
<tr>
<td>Average</td>
<td>—</td>
<td>-1.6</td>
<td>2.7</td>
<td>15.2</td>
<td>38.5</td>
<td>65.9</td>
</tr>
<tr>
<td>Google 20-Year Annualized Return</td>
<td>—</td>
<td>—</td>
<td>—</td>
<td>—</td>
<td>17.3</td>
<td>—</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Source: Author&#8217;s own elaboration based on TradingView data</figcaption></figure>
<h2 class="wp-block-heading">Is Alphabet Stock Set To Rally Again?</h2>
On March 28, 2025, Alphabet was trading at $154.33 with a P/E of around 17.1. Since then, the stock has posted a modest 10.2% gain over the past three months.
While past performance doesn&#8217;t guarantee future results, the data suggests that patient investors buying at these discounted multiples have often been rewarded.
Read now: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46217099/autonomous-vehicles-best-stocks">Autonomous Vehicles Hit Their &#8216;ChatGPT Moment&#8217; — Best Stocks To Watch Now</a></li>
</ul>
Photo: Shutterstock

Equities

Large Cap

Tech

GOOGL

This Magnificent 7 Stock Is Absurdly Cheap – It Probably Won't Stay That Way For Long

CleanSpark Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLSK#NASDAQ">CLSK</a>) shares are trading sharply higher Wednesday morning. The stock is trending across social media platforms after B. Riley Securities initiated coverage with a Buy rating and a price target of $16, citing the Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) miner&#8217;s clear growth trajectory and focused strategy.
What To Know: The firm highlighted that CleanSpark has successfully met its mid-year operating hash rate target of 50 exahashes per second ahead of schedule, with a new goal of 57 EH/s on the horizon. 
With over 1 gigawatt of operational capacity, analysts see significant opportunities for further expansion at its sites in Georgia, Mississippi, Tennessee and Wyoming.
B. Riley praised CleanSpark&#8217;s &#8220;unapologetically BTC focused&#8221; business model, noting the company&#8217;s commitment to pure-play bitcoin mining sets it apart from competitors diversifying into other areas. This focus on securing low-cost power in rural America is seen as a core strength.
The report also pointed to the company&#8217;s new Digital Asset Management division, launched in April 2025. This arm aims to generate additional revenue by strategically managing its treasury of 12,502 BTC. Analysts believe CleanSpark represents the most straightforward investment for investors seeking exposure to hash rate growth at scale in the public markets.
Price Action: According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, CLSK shares are trading higher by 11.4% to $12.35 Wednesday morning. CLSK has a 52-week high of $20.49 and a 52-week low of $6.46.
Read Also: <a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/46162253/japanese-bitcoin-stock-michael-saylor-inspired-company-leaves-galaxy-cleanspark-trailing-becomes-fifth-largest-btc-corporate-holder">Japanese Bitcoin Stock: Michael Saylor-Inspired Company Leaves Galaxy, CleanSpark Trailing, Becomes Fifth-Largest BTC Corporate Holder</a>
<h2 class="wp-block-heading">How To Buy CLSK Stock</h2>
By now you're likely curious about how to participate in the market for Cleanspark &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.
In the case of Cleanspark, which is trading at $12.05 as of publishing time, $100 would buy you 8.3 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
Image: Shutterstock

$BTC

CLSK

Why CleanSpark (CLSK) Stock Is Surging

CN (TSX:<a class="ticker" href="https://www.benzinga.com/stock/CNR#TSX">CNR</a>) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNI#NYSE">CNI</a>) announced today plans to invest approximately US$110 million in Wisconsin, as part of its <a href="https://www.globenewswire.com/Tracker?data=zjges5a8GPjLwRw7ztkm3pPbXv7sTIZiCnBVfS-_ika3sE6oq54TY4mQMMnjF-wIqGRJEA4HY4PrXBgXtmKb1x92eOZjlHF-NO5MZf56JPUlHGjZa5X69HOeRrugMrAfSmA9_YBjF11Z1oYstpN7hUvo_oRroImBCAwRU9fBF7bN23jkNMdR9oOSkKQ-E4ZYYp9lZ5qMaOoUuHa1ctk9aQ==">2025 capital investment program</a>. This investment will support track maintenance and strategic infrastructure initiatives in the state. This includes investments in infrastructure, technology and capacity, as well as network improvements. These projects will help ensure the safe movement of goods and support long-term sustainable growth in Chicago and across CN's network.

Contracts

TSX:CNR

CN To Invest ~$110M In Wisconsin Rail Infrastructure As Part Of 2025 Capital Program

Robinhood Markets Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>) shares hit a new all-time high Wednesday, following a series of major announcements revealing a more comprehensive push into the cryptocurrency space. 
Additionally, KeyBanc Capital Markets on Monday increased its price target for the stock to $110 from $60, maintaining an Overweight rating. Here&#8217;s what investors <a href="https://www.benzinga.com/quote/HOOD/news">need to know</a>.
What To Know: KeyBanc analysts, including Alex Markgraff, cited Robinhood&#8217;s &#8220;first-rate innovation&#8221; and &#8220;TAM expansion&#8221; as primary drivers for the upgrade.
The revision follows Robinhood&#8217;s <a href="https://www.benzinga.com/crypto/25/06/46174854/robinhood-just-made-crypto-simpler-and-way-more-powerful">first crypto user event</a> in Cannes, France and strong intra-quarter data. Key announcements included the launch of commission-free tokenized U.S. equities for EU users and the introduction of perpetual futures with up to 3x leverage in the same region. 
These initiatives, along with the expansion of crypto trading to the entire European Union, signal a clear roadmap for international growth.
The report also reflects updated financial estimates, factoring in better-than-expected April-June data and the anticipated revenue from the Bitstamp acquisition. 
KeyBanc projects 2025 revenue of $3.77 billion and GAAP EPS of $1.31. The new $110 price target is based on 83.5x the firm&#8217;s 2025 GAAP EPS estimate. KeyBanc also outlined a bull case of $130 and a bear case of $65.
Also of note, CEO Vlad Tenev <a href="https://www.benzinga.com/crypto/25/06/46174854/robinhood-just-made-crypto-simpler-and-way-more-powerful">stated</a> this week that the company aims to establish &#8216;crypto as the backbone of the global financial system.&#8217;
This strategic expansion also includes the development of its own Layer 2 blockchain on Arbitrum, designed to support tokenized assets and self-custody, signaling a transformative vision for the future of finance.
Price Action: According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, HOOD shares are trading higher by 7.1% to $98.86 Wednesday morning. HOOD has a 52-week high of $100.29 and a 52-week low of $13.98.
Read Also: <a href="https://www.benzinga.com/analyst-stock-ratings/price-target/25/07/46204175/robinhood-to-rally-more-than-17-here-are-10-top-analyst-forecasts-for-tuesday">Robinhood To Rally More Than 17%? Here Are 10 Top Analyst Forecasts For Tuesday</a>
<h2 class="wp-block-heading">How To Buy HOOD Stock</h2>
By now you're likely curious about how to participate in the market for Robinhood Markets &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.
In the case of Robinhood Markets, which is trading at $97.64 as of publishing time, $100 would buy you 1.02 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
Image: Shutterstock

HOOD

Robinhood Stock Surges To All-Time High On Aggressive Crypto Expansion: What's Going On?

Applied Mat (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMAT#NASDAQ">AMAT</a>) has outperformed the market over the past 20 years by 4.24% on an annualized basis producing an average annual return of 12.7%. Currently, Applied Mat has a market capitalization of $152.74 billion. 
Buying $100 In AMAT: If an investor had bought $100 of AMAT stock 20 years ago, it would be worth $1,128.09 today based on a price of $187.94 for AMAT at the time of writing.
<h3>Applied Mat's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751471119_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AMAT

$100 Invested In This Stock 20 Years Ago Would Be Worth This Much Today

High-end auctions are famous for having rare collectibles, but sometimes the story behind the items up for bid can be as interesting as the item itself. This was the case recently in Paris, where a collection of ultra-rare<a href="https://www.benzinga.com/markets/guidance/25/06/45928561/gold-biggest-boom-in-decades-and-investors-are-still-missing-out"> gold</a> coins was sold for nearly $3.5 million. That part isn't unusual, but the coin's origin story defies belief. They were found hidden in the walls of their former owner's home.
Paris-based auction house, Beaussant Lefèvre &amp; Associates, conducted the sale, according to <a href="https://www.cnn.com/2025/06/12/europe/france-coin-collection-auction-scli-intl">CNN</a>. The more details they provided about the coin's history, the more unbelievable the story became. The coin's original owner was a man named Paul Narce. By all accounts, he was a quiet and unassuming man, and he kept his passion for coin collecting secret from all but a few people in his life.
Don't Miss:
<ul class="wp-block-list">
<li>Named a TIME Best Invention and Backed by 5,000+ Users, Kara's Air-to-Water Pod Cuts Plastic and Costs — <a href="https://www.benzinga.com/money/americans-spend-1000-per-year-on-plastic-water-bottles-kara-pod-gives-you-clean-drinking-water-by-pulling-moisture-from-the-air">And You Can Invest At Just $6.37/Share</a></li>
<li>Tired of Grid Failures and Charging Deserts? This Startup Has a Solar Fix and $25M+ in Sales — <a href="https://www.benzinga.com/money/meet-the-company-seeking-to-give-americans-energy-independence-and-learn-how-you-can-become-an-early-investor">Now Raising at $3/Share</a></li>
</ul>
Some of the oldest coins in Narce's collection are from the ancient Kingdom of Macedonia and could date as far back as 323 B.C. Narce also had a complete set of coins from French monarchs, Louis XIV, Louis XV, and Louis XVI. It's the kind of coin collection you would expect to be owned by a wealthy French businessman who travelled the world to find them, but that was not Narce's story.
"Narce, who lived a modest life and didn't see a lot of the world, spent all of his money on his collection," coin expert Thierry Parsy in a <a href="https://cdn.drouot.com/d/catalogue?path=92/164016/397-BL_1011_06_25_BD.pdf">public statement</a> advertising the sale. He spent much of his life amassing the collection, which Parsy described as "exceptional both in number, with more than 1,000 pieces, as well as the rarities it contains." Parsy also said that many of Narce's coins were several hundred years old.
According to Parsy, Narce died without any heirs, and only a few people in his inner circle knew he collected coins, and Parsy told CNN that none of them had any idea where he kept the coins. Complicating matters further, Narce checked into a managed care facility about a year before he died. His coins "could have remained undiscovered forever," said Parsy.
Trending: Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wiseradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation.&nbsp;</a>
If it weren't for the efforts of an enterprising notary in the small Southwestern French village where Narce lived, Narce's collection may have never been found. According to CNN, the&nbsp; notary searched Narce's former home and found the coin collection in a storeroom. Narce had tucked the coins away in between the walls of the storeroom and behind a painting hanging on the wall. It's quite obvious Narce put a very high premium on security and being secretive.
CNN also said&nbsp; that old coins weren't the only currency Narce collected. The notary also found a trove of 20-franc gold coins. Narce may have been a private man, but his instincts about collecting gold coins proved to be spot on.<a href="https://www.benzinga.com/markets/commodities/25/06/45930322/gold-vs-bitcoin-we-now-know-which-is-the-real-safe-haven"> Gold prices</a> have been skyrocketing for much of the year. CNN reported that the $3.5 million final hammer price was significantly higher than pre-auction estimates and the current premium on gold could explain the high price. It's too bad Narce didn't get to enjoy the profits his coin collection generated..&nbsp;
Read Next:&nbsp;
<ul class="wp-block-list">
<li>Invest early in CancerVax's breakthrough tech aiming to disrupt a $231B market. <a href="https://www.benzinga.com/money/this-company-may-have-found-a-way-to-treat-cancer-by-tricking-the-bodys-immune-system-and-early-studies-show-some-promise-find-out-how-you-can-invest-in-the-future-of-cancer-treatment">Back a bold new approach to cancer treatment with high-growth potential.</a></li>
<li>Can you guess how many retire with a $5,000,000 nest egg? <a href="https://www.benzinga.com/money/5mil-nest-egg-adv">The percentage may shock you</a>.</li>
</ul>
Image: Shutterstock

Personal Finance

Reclusive French Collector Hid Nearly $3.48 Million In Rare Gold Coins In The Walls Of His Home

WIIM

ZVRA

Zevra Therapeutics are trading higher after HC Wainwright & Co initiated coverage on the stock with a Buy rating and announced a $26 price target.

Barclays analyst Amos Fletcher maintains Vale (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VALE#NYSE">VALE</a>) with a Overweight and raises the price target from $12.75 to $13.

VALE

Barclays Maintains Overweight on Vale, Raises Price Target to $13

Unifirst Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNF#NYSE">UNF</a>) shares are trading <a target="_blank" href="https://www.benzinga.com/movers" rel="noreferrer noopener">lower on Wednesday.</a>
The company reported third-quarter adjusted earnings per share of $2.17, beating the <a target="_blank" href="https://www.benzinga.com/pressreleases/25/07/g46217276/unifirst-announces-financial-results-for-the-third-quarter-of-fiscal-2025" rel="noreferrer noopener">analyst consensus estimate of $2.09</a>.
Quarterly sales of $610.778 million (+1.2% year over year) missed the Street view of $614.51 million.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/market-summary/25/07/46221687/us-stocks-mixed-unifirst-shares-fall-after-q3-results" rel="noreferrer noopener">US Stocks Mixed; UniFirst Shares Fall After Q3 Results</a>
Core Laundry Operations reported a 0.9% year-over-year revenue increase, reaching $533.2 million for the quarter. Organic growth, excluding acquisitions and currency impacts, came in slightly higher at 1.1%.
Operating income was $48.2 million, a decrease of 0.6% year over year. Operating margin contracted slightly to 7.9% in the quarter, compared with 8% a year ago.
The company&#8217;s financial results for the third quarter included approximately $1 million of costs directly attributable to its customer relationship management computer system and enterprise resource planning projects.&nbsp;
Adjusted EBITDA increased to $85.8 million compared to $84.8 million in the prior year, or 1.2%. Adjusted EBITDA margin remained flat on a year-over-year basis at 14.1%.
As of May 31, the company held $211.9 million in cash, equivalents, and short-term investments.
It repurchased $13.6 million of common stock during the third quarter, with $86.4 million still available under its current buyback authorization.
Outlook: UniFirst raised its fiscal year GAAP earnings per share guidance to a range of $7.60–$8.00, up from the prior $7.30–$7.70, compared with the $7.56 consensus estimate.
The company reaffirmed its sales outlook of $2.422 billion to $2.432 billion, compared with the $2.428 billion estimate.
Price Action: UNF shares are trading lower by 4.9% to $181.00 at last check Wednesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/movers/25/07/46220764/stellantis-under-new-federal-recall-investigation-for-gear-shifter-issue" target="_blank" rel="noreferrer noopener">Stellantis Under New Federal Recall Investigation For Gear Shifter Issue</a></li>
</ul>
Photo: Shutterstock

Earnings

Guidance

Markets

Movers

General

Can UniFirst Rise Above Doubts After Mixed Q3 Results?

ARCT

Arcturus Therapeutics Holdings shares are trading higher after Scotiabank maintained a Sector Outperform and raised its price target from $32 to $35.

JP Morgan initiates coverage on Qifu Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QFIN#NASDAQ">QFIN</a>) with a Overweight rating and announces Price Target of $65.

Initiation

QFIN

JP Morgan Initiates Coverage On Qifu Technology with Overweight Rating, Announces Price Target of $65

UUUU

Energy Fuels shares are trading higher after Canaccord Genuity upgraded the stock from Speculative Buy to Buy and raised its price target from C$9.5 to C$9.75.

Compass Point analyst Merrill Ross downgrades Strawberry Fields REIT (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/STRW#AMEX">STRW</a>) from Buy to Neutral and lowers the price target from $12.2 to $10.65.

Downgrades

STRW

Compass Point Downgrades Strawberry Fields REIT to Neutral, Lowers Price Target to $10.65

Enovix Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENVX#NASDAQ">ENVX</a>) shares are trading higher Wednesday morning. The company earlier revealed that its Board of Directors has given the green light for a share repurchase program. The company is now <a href="https://www.benzinga.com/pressreleases/25/07/g46217964/enovix-corporation-announces-share-repurchase-program">authorized</a> to buy back up to $60 million of its outstanding common stock.
What To Know: Enovix says this strategic move is intended to afford Enovix greater agility in managing its capital structure. The company stated the program will enable it to better navigate market volatility and enhance shareholder value. 
Share <a href="https://www.benzinga.com/pressreleases/25/07/g46217964/enovix-corporation-announces-share-repurchase-program">repurchases</a> may occur through various methods, including open-market and privately negotiated transactions, all contingent on market conditions and regulatory compliance.
Ryan Benton, Chief Financial Officer of Enovix, expressed strong confidence in the company&#8217;s trajectory. &#8220;This repurchase program reflects our confidence in the company&#8217;s long-term fundamentals and the strength of our 100% silicon-anode battery technology,&#8221; Benton remarked.
Price Action: According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, ENVX shares are trading higher by 8.3% to $10.97 Wednesday morning. ENVX has a 52-week high of $18.68 and a 52-week low of $5.27.
Read Also: <a href="https://www.benzinga.com/pressreleases/25/07/g46217964/enovix-corporation-announces-share-repurchase-program">Enovix Corporation Announces Share Repurchase Program</a>
<h2 class="wp-block-heading">How To Buy ENVX Stock</h2>
By now you're likely curious about how to participate in the market for Enovix &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.
In the case of Enovix, which is trading at $11.44 as of publishing time, $100 would buy you 8.74 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
Image: Shutterstock

ENVX

Enovix (ENVX) Stock Is Surging Wednesday: What's Driving The Action?

Canaccord Genuity analyst Maria Ripps maintains Spotify Technology (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPOT#NYSE">SPOT</a>) with a Buy and raises the price target from $775 to $850.

SPOT

Canaccord Genuity Maintains Buy on Spotify Technology, Raises Price Target to $850

Truist Securities analyst Jake Bartlett maintains Texas Roadhouse (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXRH#NASDAQ">TXRH</a>) with a Buy and raises the price target from $201 to $212.

TXRH

Truist Securities Maintains Buy on Texas Roadhouse, Raises Price Target to $212

Truist Securities analyst Jake Bartlett maintains Shake Shack (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHAK#NYSE">SHAK</a>) with a Buy and raises the price target from $140 to $150.

SHAK

Truist Securities Maintains Buy on Shake Shack, Raises Price Target to $150

Press Releases

Sight Sciences to Report Fourth Quarter and Full Year 2024 Financial Results on March 5, 2025

Sight Sciences to Present Comprehensive Clinical Data on the OMNI® Surgical System at the 2025 American Glaucoma Society Annual Meeting

Health Care

Sight Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Initiates Full Year 2025 Financial Guidance

Sight Sciences to Present at the 24th Annual Needham Healthcare Conference on April 8th

Sight Sciences to Debut OMNI® Edge Surgical System at the 2025 ASCRS Annual Meeting, Expanding the OMNI Product Portfolio

Management

Sight Sciences Appoints Gary Burbach to its Board of Directors

Sight Sciences Announces the Release of its Sustainability Report

Sight Sciences to Report First Quarter 2025 Financial Results on May 8, 2025

Sight Sciences Reports First Quarter 2025 Financial Results and Reaffirms Full Year 2025 Revenue Guidance

Sight Sciences to Present at the Stifel 2025 Virtual Ophthalmology Forum on May 27th

Comments

Sight Sciences

Vendite allo scoperto

Sight Sciences (NASDAQ:SGHT) Azioni, Report sulle vendite allo scoperto

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO